Biotech investors in Guangdong, China
Updated 16 Nov 2026
Venture funds
4 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Green Pine Capital Partners Green Pine Capital Partners is a venture firm whose recent companies include RealAI and MindRank AI. Shenzhen, China |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 32% | 2 |
| 2 | SZHTI Group SZHTI Group provides asset management and financing services, including investments tied to Elegoo and SpinQ Technology. Shenzhen, China |
Hardware, Biotech | Early stage venture | 30% | 2 |
| 3 | Tiantu Capital Tiantu Capital is a venture capital association, with recent investments in Xellar Biosystems and Leman Biotech. Shenzhen, China |
Commerce, Artificial intelligence | Seed, Early stage venture | 52% | 2 |
| 4 | Zhengxuan Investment Zhengxuan Investment invests in high-tech enterprises, with recent companies Yuce Biotechnology and Xellar Biosystems. Shenzhen, China |
Hardware, Artificial intelligence | Seed, Early stage venture | 49% | 2 |
Table 1. Biotech investors in Guangdong, China: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Fortune Venture Capital | Venture capital firm | Shenzhen, China | •••@fortunevc.com | |
| Oriental Fortune Capital | Venture capital firm | Shenzhen, China | •••@ofcapital.com | +86-75••• |
| Green Pine Capital Partners | Venture capital firm | Shenzhen, China | •••@pinevc.com.cn | +86 75••• |
| Shenzhen Guozhong Venture Capital Management | Venture capital firm | Shenzhen, China | •••@gzvcm.com | 0755-8••• |
| Tiantu Capital | Venture capital firm | Shenzhen, China | •••@tiantu.com.cn | +86-07••• |
| EFung Capital | Private equity firm | Shenzhen, China | •••@efungcapital.com | 0755-8••• |
| Zhengxuan Investment | Venture capital firm | Shenzhen, China | •••@zxholdings.com | (+86) ••• |
| Yael Capital Management Limited | Venture capital firm | Shenzhen, China | •••@yaelcapital.com |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 13 of the 22 biotech investors in Guangdong, China have a published email address, 16 a phone number and 22 a website.
- Fortune Venture Capital has the most recorded investments, 366, 140 of them as lead investor.
- 19 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Fortune Venture Capital is an investor in 15 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Huasaiboman Medical Cell Biology's $30.0M Series B on 9 November 2026.
- Software is the most common sector across their 480 portfolio companies (65%).
- Early stage venture is the most common investment stage, recorded for 21 of them (95%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in Guangdong, China
22 of 22, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | Hardware, Artificial intelligence | Global Technology, Zhongke Ruijian, Xunjie Guangyuan | 15 | 366 | 140 | 47 | •••@fortunevc.com | In the CSV | |
| 2 | Oriental Fortune Capital | Venture capital firm | Shenzhen, China | Hardware, Artificial intelligence | Micronano Core, Renshuo Solar, EVAS Intelligence | 9 | 342 | 117 | 32 | •••@ofcapital.com | +86-75••• | In the CSV |
| 3 | Haiyuan Capital | Venture capital firm | Shenzhen, China | Health care, Biotech | Hongxin Biology | 1 | 70 | 40 | 3 | |||
| 4 | Green Pine Capital Partners | Venture capital firm | Shenzhen, China | Hardware, Artificial intelligence | RealAI, MindRank AI, Jiangxing Intelligence | 5 | 271 | 86 | 25 | •••@pinevc.com.cn | +86 75••• | In the CSV |
| 5 | Shenzhen Guozhong Venture Capital Management | Venture capital firm | Shenzhen, China | Hardware, Artificial intelligence | Barty Medical, Sinsegye | 2 | 132 | 50 | 17 | •••@gzvcm.com | 0755-8••• | In the CSV |
| 6 | Cowin Capital | Private equity firm | Shenzhen, China | Hardware, Artificial intelligence | ExponTech, Sinsegye, Leadinno Medical Valley | 7 | 382 | 167 | 38 | +07558••• | In the CSV | |
| 7 | Tiantu Capital | Venture capital firm | Shenzhen, China | Commerce, Artificial intelligence | Xellar Biosystems, Leman Biotech | 2 | 155 | 81 | 19 | •••@tiantu.com.cn | +86-07••• | In the CSV |
| 8 | SZHTI Group | Venture capital firm | Shenzhen, China | Hardware, Biotech | Chuangzhi Lianheng, SpinQ Technology, Chuangxiang Digital | 9 | 131 | 39 | 12 | 0755-8••• | In the CSV | |
| 9 | Guangzhou Yuexiu Industrial Investment Fund | Corporate venture arm | Guangzhou, China | Health care, Biotech | EVAS Intelligence, Sonosemi Medical | 2 | 82 | 31 | 13 | In the CSV | ||
| 10 | EFung Capital | Private equity firm, Venture capital firm | Shenzhen, China | Health care, Biotech | JGene Biotechnology | 1 | 80 | 30 | 12 | •••@efungcapital.com | 0755-8••• | In the CSV |
| 11 | Zhengxuan Investment | Venture capital firm | Shenzhen, China | Hardware, Artificial intelligence | Yuce Biotechnology, Qiaojie Digital, Xellar Biosystems | 4 | 61 | 30 | 2 | •••@zxholdings.com | (+86) ••• | In the CSV |
| 12 | Yael Capital Management Limited | Venture capital firm | Shenzhen, China | Biotech, Health care | Xellar Biosystems | 1 | 18 | 2 | 1 | •••@yaelcapital.com | In the CSV | |
| 13 | QF Capital | Private equity firm, Venture capital firm | Shenzhen, China | Artificial intelligence, Hardware | Utarn Technology, Traverser, LaiHua | 9 | 191 | 80 | 14 | •••@qfcapital.com.cn | +07558••• | In the CSV |
| 14 | Tianjin Venture Capital | Venture capital firm | Tianjin, China | Biotech, Health care | Yunyao Aerospace Technology, JGene Biotechnology | 2 | 103 | 15 | 22 | 022-86••• | In the CSV | |
| 15 | CDF-Capital | Private equity firm, Venture capital firm | Shenzhen, China | Hardware, Artificial intelligence | Shuangxin Microelectronics | 1 | 87 | 39 | 10 | •••@cdfcn.com | 0755-8••• | In the CSV |
| 16 | Vinno Capital | Venture capital firm | Shenzhen, China | Hardware, Biotech | Beijing Ruidaen Technology Co., JGene Biotechnology | 2 | 34 | 15 | 0 | 0755-8••• | ||
| 17 | ASBV | Venture capital firm | Shenzhen, China | Health care, Biotech | Huasaiboman Medical Cell Biology | 1 | 28 | 13 | 0 | •••@asbvchina.com | 0755-2••• | In the CSV |
| 18 | Longmen Capital | Venture capital firm | Shenzhen, China | Biotech, Health care | SmartNuclide, Innovo Therapeutics | 24 | 4 | 2 | •••@longmencapital.com | 0756-8••• | ||
| 19 | Winzac Capital | Venture capital firm | Shenzhen, China | Biotech, Health care | USK Biotech, Sinogen Biopharma | 22 | 9 | 2 | ||||
| 20 | Thunderstorm VC | Venture capital firm | Guangzhou, China | Biotech, Health care | Saicun Biotechnology, Leyi Biology, Shenzhen AOE Network Technology | 21 | 5 | 1 | ||||
| 21 | Danen Capital | Venture capital firm | Shenzhen, China | Biotech, Fintech | SynMetaBio | 1 | 20 | 2 | 1 | •••@danencap.com | +86 07••• | In the CSV |
| 22 | CHERAMI | Private equity firm | Guangzhou, China | Health care, Artificial intelligence | MindRank AI | 1 | 19 | 6 | 5 | 020-38••• | In the CSV |
Table 2. Biotech investors in Guangdong, China: the first 22 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 22.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Fortune Venture Capital | Shenzhen, China | 15 | 79 | Global Technology, Zhongke Ruijian, Xunjie Guangyuan |
| 2 | Oriental Fortune Capital | Shenzhen, China | 9 | 93 | Micronano Core, Renshuo Solar, EVAS Intelligence |
| 3 | QF Capital | Shenzhen, China | 9 | 39 | Utarn Technology, Traverser, LaiHua |
| 4 | SZHTI Group | Shenzhen, China | 9 | 30 | Chuangzhi Lianheng, SpinQ Technology, Chuangxiang Digital |
| 5 | Cowin Capital | Shenzhen, China | 7 | 72 | ExponTech, Sinsegye, Leadinno Medical Valley |
| 6 | Green Pine Capital Partners | Shenzhen, China | 5 | 53 | RealAI, MindRank AI, Jiangxing Intelligence |
| 7 | Zhengxuan Investment | Shenzhen, China | 4 | 18 | Yuce Biotechnology, Qiaojie Digital, Xellar Biosystems |
| 8 | Shenzhen Guozhong Venture Capital Management | Shenzhen, China | 2 | 22 | Barty Medical, Sinsegye |
| 9 | Guangzhou Yuexiu Industrial Investment Fund | Guangzhou, China | 2 | 9 | EVAS Intelligence, Sonosemi Medical |
| 10 | Tiantu Capital | Shenzhen, China | 2 | 20 | Xellar Biosystems, Leman Biotech |
| 11 | Tianjin Venture Capital | Tianjin, China | 2 | 9 | Yunyao Aerospace Technology, JGene Biotechnology |
| 12 | Vinno Capital | Shenzhen, China | 2 | 7 | Beijing Ruidaen Technology Co., JGene Biotechnology |
| 13 | ASBV | Shenzhen, China | 1 | 5 | Huasaiboman Medical Cell Biology |
| 14 | Haiyuan Capital | Shenzhen, China | 1 | 16 | Hongxin Biology |
| 15 | CHERAMI | Guangzhou, China | 1 | 5 | MindRank AI |
Table 3. Biotech investors in Guangdong, China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Huasaiboman Medical Cell Biology | Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. | Biotech | Qingdao Shi, China | Series B | $30.0M | 2026-11-09 | $30.0M | ASBV | 11 to 50 | 2019 |
| Global Technology | Global Technology supplies automotive intelligent driving systems. | Hardware | Mumbai, India | Series C | $90.0M | 2026-11-03 | $153.9M | Fortune Venture Capital | 101 to 250 | 2001 |
| Zhongke Ruijian | Zhongke Ruijian provides an AI-based counterfeit detection platform for digital content security. | Artificial intelligence | Hangzhou, China | Series A | $14.0M | 2026-11-03 | $14.0M | Fortune Venture Capital | 11 to 50 | 2020 |
| Micronano Core | Micronano Core develops and researches AIoT chip products for intelligent IoT and advanced technology applications. | Artificial intelligence | Hangzhou, China | Series C | $150.0M | 2026-10-28 | $490.5M | Oriental Fortune Capital | 11 to 50 | 2021 |
| Renshuo Solar | Renshuo Solar manufactures perovskite tandem solar panels. | Energy | Suzhou, China | Series B | $15.0M | 2026-10-22 | $15.0M | Oriental Fortune Capital | 51 to 100 | 2021 |
| Utarn Technology | Utarn Technology develops spiking neural network technology. | Artificial intelligence | Hangzhou, China | Series A | $15.0M | 2026-10-22 | $15.0M | QF Capital | 51 to 100 | 2019 |
| ExponTech | ExponTech provides data infrastructure solutions built on distributed architecture. | Hardware | Luoyang, China | Series A | $15.0M | 2026-10-20 | $43.6M | Cowin Capital | 101 to 250 | 2020 |
| Xunjie Guangyuan | Xunjie Guangyuan develops near-infrared spectroscopy analysis instruments. | Artificial intelligence | Wuxi Shi, China | Series B | $14.9M | 2026-09-28 | $29.0M | Fortune Venture Capital | 51 to 100 | 2016 |
| Barty Medical | Barty Medical provides hospital healthcare services to patients. | Health care | Hangzhou, China | Series D | $29.5M | 2026-09-23 | $46.7M | Shenzhen Guozhong Venture Capital Management | 101 to 250 | 2015 |
| EVAS Intelligence | EVAS Intelligence develops AI chips, semiconductor architectures, and software for autonomous driving. | Artificial intelligence | Beijing, China | Series D | $298.5M | 2026-09-18 | $605.2M | Oriental Fortune Capital, Guangzhou Yuexiu Industrial Investment Fund | 101 to 250 | 2022 |
Table 4. Biotech investors in Guangdong, China: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 314 | 65% |
| Hardware | 144 | 30% |
| Artificial intelligence | 87 | 18% |
| Health care | 76 | 16% |
| Biotech | 50 | 10% |
| Fintech | 42 | 9% |
| Commerce | 32 | 7% |
| Education | 26 | 5% |
| Energy | 13 | 3% |
| Cybersecurity | 13 | 3% |
Table 5. Biotech investors in Guangdong, China: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 21 | 95% |
| Seed investors | 12 | 55% |
| Late stage investors | 9 | 41% |
| Venture investors | 7 | 32% |
| Post IPO investors | 3 | 14% |
| Private equity investors | 3 | 14% |
| Debt investors | 2 | 9% |
Table 6. Biotech investors in Guangdong, China by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2010s | 10 | 48% |
| 2000s | 9 | 43% |
| 1990s | 2 | 10% |
Table 8. Biotech investors in Guangdong, China by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in Guangdong, China. On 16 November 2026 that is 22 investors.
- 13 rows carry an email address and 16 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 22 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 22 rows: 0 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in Guangdong, China are on the list?
- 22, in the file dated 16 November 2026. 19 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 13 of the 22 carry an email address in the download and 16 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 22 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 22 rows, 13 firm email addresses and 16 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 5 of the 13 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.